Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Charlie Hospital Semarang Tbk. (RSCH) vs Suparma Tbk. (SPMA) Price & Performance

Charlie Hospital Semarang Tbk.Trade
Suparma Tbk.Trade

Price performance (Past 24H)

Key statistics

Charlie Hospital Semarang Tbk. vs Suparma Tbk. — how do they compare? Charlie Hospital Semarang Tbk. trades at Rp270 (market cap 742B, 29.45M 24h volume), while Suparma Tbk. trades at Rp172 (market cap 701.15B, 378K 24h volume). The key difference: Charlie Hospital Semarang Tbk. and Suparma Tbk. are close in size by market cap, and Charlie Hospital Semarang Tbk. is more actively traded (29.45M versus 378K). Which is the better fit depends on your goals.

RSCHSPMA
Market Cap
742B701.15B
Volume
29.45M378K
Lot
294.49K3.78K
Turnover
8.14B64.09M
Average Price
276.35169.54
Value
8.14B64.09M
Indicative Equilibrium Price
270171
Indicative Equilibrium Volume
103300

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

RSCH
View details
SPMA
View details

About Charlie Hospital Semarang Tbk.

PT Charlie Hospital Semarang, Tbk (the "Company") was established based on Deed No. 35 dated 11 February 2019, which was made before Notary Nur Hadi, SH, MKn, notary in Kendal Regency and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia based on Decree No. AHU-0008598.AH.01.01. Year 2019 February 11, 2019. The company started its commercial operations on September 23, 2019.

Read more on RSCH

About Suparma Tbk.

PT Suparma Tbk (Entity) was established under the Domestic Capital Investment Law No. 6 of 1968 as amended by Law No. 12 of 1970 based on the Notarial Deed No. 29 of Tjahjadi Hartanto, S.H., on August 25, 1976. The Entity's name, PT Supar Inpama was changed to PT Suparma based in the Notarial Deed No. 5 dated December 7, 1978 of the same notary.

Read more on SPMA